LRMR NASDAQ
Larimar Therapeutics, Inc.
1W: -3.9%
1M: -23.5%
3M: -10.0%
YTD: -14.7%
1Y: -28.7%
3Y: -34.1%
5Y: -76.2%
$2.96
-0.10 (-3.27%)
Weekly Expected Move ±10.0%
$2
$3
$3
$3
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-173M
Net Income
-73.0% YoY
$-156M
Free Cash Flow
-68.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-139.6%
ROA-109.5%
ROIC590.9%
Valuation
P/E-1.5
P/B2.4
EV/EBITDA-1.0
Leverage
Debt/Equity0.04
Current Ratio4.70
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z-1.73
Beneish M0.00